Turku Bioscience

Turku Bioscience

Turku, Finland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2M

Overview

Turku Bioscience is a long-established, university-hosted core facility and research centre that provides essential technological infrastructure and expertise in proteomics and genomics to over 200 researchers. Its business model is service-based, supporting both academic and potentially external research through its 11 core facilities while also conducting its own discovery research through 28 affiliated groups. The centre is a key node in the Finnish and European life science ecosystem, driving high-impact publications and fostering collaboration, but its financial model is likely dependent on institutional funding, grants, and user fees rather than product commercialization.

OncologyMetabolic DiseaseAutoimmune DiseaseCardiovascular Disease

Technology Platform

A suite of 11 shared core facilities providing advanced technologies and expert support in areas including functional genomics, advanced imaging, proteomics, and protein structure/chemistry. It is an integrated infrastructure platform for omics and imaging research.

Funding History

1
Total raised:$2M
Grant$2M

Opportunities

Growing demand for complex omics and imaging services from academia and the biopharma industry presents a chance to expand fee-for-service work.
The centre is also poised to translate foundational research from its affiliated groups into commercial opportunities via spin-out companies or licensing deals.

Risk Factors

Financial sustainability is heavily tied to competitive grant funding and institutional budgets, which can be volatile.
The rapid pace of technological change requires constant capital investment to avoid obsolescence of core facilities.

Competitive Landscape

Competes with other academic core facilities and non-profit research institutes across Europe for talent, grants, and service contracts. Also faces competition from large, global CROs that offer similar omics services but may lack the deep collaborative academic environment Turku Bioscience provides.